首页> 外国专利> NEW RECOMBINANT PROTEIN OF CRISIS-PREVENTING ANTIGEN ORIGINATED FROM AVIBACTERIUM PARAGALLINARUM TYPE C BACTERIUM

NEW RECOMBINANT PROTEIN OF CRISIS-PREVENTING ANTIGEN ORIGINATED FROM AVIBACTERIUM PARAGALLINARUM TYPE C BACTERIUM

机译:伞形C型细菌原发性抗危机抗原重组蛋白

摘要

PROBLEM TO BE SOLVED: To provide a protein of an effective and excellently safe antigen against Avibacterium paragallinarum type C bacterium, to provide a method for immunizing a nonhuman animal by using the protein, and to provide a monoclonal antibody suitably usable for preparing the protein, and a hybridoma.;SOLUTION: The recombinant protein is produced from a specific base sequence or amino acid sequence, reacts with a monoclonal antibody (MAb)Hpg8C1C produced by a hybridoma of accession number FERM P-21060, is contained in an inactivated whole microbe immune serum of the Avibacterium paragallinarum type C bacterium, and absorbs a serum-specific hemagglutination inhibition (HI) antibody. The method for immunizing the nonhuman animal, especially birds involves inducing a serum-type specific HI antibody titer by subcutaneous or intramuscular administration of the recombinant protein to the nonhuman animal.;COPYRIGHT: (C)2008,JPO&INPIT
机译:要解决的问题:提供一种有效且安全性极高的抗C型副乳杆菌细菌抗原的蛋白质,提供一种使用该蛋白质免疫非人类动物的方法,并提供适用于制备该蛋白质的单克隆抗体,解决方案:重组蛋白由特定的碱基序列或氨基酸序列产生,并与登录号为FERM P-21060的杂交瘤产生的单克隆抗体(MAb)Hpg8C1C反应,包含在灭活的整个微生物中C型副鸡空肠杆菌的免疫血清,并吸收血清特异性血凝抑制(HI)抗体。免疫非人类动物特别是鸟类的方法包括通过对非人类动物皮下或肌肉内注射重组蛋白来诱导血清型特异性HI抗体滴度。;版权所有:(C)2008,JPO&INPIT

著录项

  • 公开/公告号JP2008156317A

    专利类型

  • 公开/公告日2008-07-10

    原文格式PDF

  • 申请/专利权人 BISEIBUTSU KAGAKU KENKYUSHO:KK;

    申请/专利号JP20060349688

  • 发明设计人 OISHI EIJI;NORO TAICHI;

    申请日2006-12-26

  • 分类号C07K14/195;C07K16/12;C12N15/09;C12N5/10;A61K39/02;A61P31/04;A61P37/04;C12P21/08;

  • 国家 JP

  • 入库时间 2022-08-21 20:23:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号